Patents by Inventor Sansan Lin

Sansan Lin has filed for patents to protect the following inventions. This listing includes patent applications that are pending as well as patents that have already been granted by the United States Patent and Trademark Office (USPTO).

  • HCV multiple epitope fusion antigens with modified proteolytic cleavage sites and uses thereof
    Patent number: 7871625
    Abstract: Modified HCV multiple epitope fusion antigens (MEFAs) are described. The proteins include modified sequences such that proteolytic cleavage of the MEFAs by HCV NS3 protease is inhibited. HCV immunoassays including the modified MEFAs are also described.
    Type: Grant
    Filed: August 26, 2005
    Date of Patent: January 18, 2011
    Assignee: Novartis Vaccines and Diagnostics, Inc.
    Inventors: David Chien, Doris Coit, Carlos George-Nascimento, Sansan Lin, Angelica Medina-Selby, Laura Tandeske
  • HCV non-structural protein mutants and uses thereof
    Patent number: 7491808
    Abstract: Modified HCV non-structural proteins are described. The proteins include modified NS3 domains such that proteolytic activity of the NS3 molecule is inhibited. The modified proteins retain conformational epitopes. HCV immunoassays including the modified NS3 molecules are also described.
    Type: Grant
    Filed: August 26, 2005
    Date of Patent: February 17, 2009
    Assignee: Novartis Vaccines and Diagnostics, Inc.
    Inventors: David Chien, Doris Coit, Celine Hu, Sansan Lin, Angelica Medina-Selby
  • Hcv Multiple Epitope Fusion Antigens With Modified Proteolytic Cleavage Sites And Uses Thereof
    Publication number: 20080299544
    Abstract: Modified HCV multiple epitope fusion antigens (MEFAs) are described. The proteins include modified sequences such that proteolytic cleavage of the MEFAs by HCV NS3 protease is inhibited. HCV immunoassays including the modified MEFAs are also described.
    Type: Application
    Filed: August 26, 2005
    Publication date: December 4, 2008
    Inventors: David Y Chien, Doris Coit, Carlos George-Nascimento, Sansan Lin, Angelica Medina-Selby, Laura Tandeske
  • Pressure-based mobility shift assays
    Patent number: 7105304
    Abstract: Methods for chromatographically separating materials, including the separation of materials in kinase or phosphatase assays, in microfluidic devices under positive or negative fluid pressure. Devices and integrated systems for performing chromatographic separations are also provided.
    Type: Grant
    Filed: November 5, 2001
    Date of Patent: September 12, 2006
    Assignee: Caliper Life Sciences, Inc.
    Inventors: Theo T. Nikiforov, Jill M. Baker, Sansan Lin, J. Wallace Parce
  • HCV non-structural protein mutants and uses thereof
    Publication number: 20060051745
    Abstract: Modified HCV non-structural proteins are described. The proteins include modified NS3 domains such that proteolytic activity of the NS3 molecule is inhibited. The modified proteins retain conformational epitopes. HCV immunoassays including the modified NS3 molecules are also described.
    Type: Application
    Filed: August 26, 2005
    Publication date: March 9, 2006
    Applicant: Chiron Corporation
    Inventors: David Chien, Doris Coit, Celine Hu, Sansan Lin, Angelica Medina-Selby
  • Pressure based mobility shift assays
    Publication number: 20050221385
    Abstract: Methods for chromatographically separating materials, including the separation of materials in kinase or phosphatase assays, in microfluidic devices under positive or negative fluid pressure. Devices and integrated systems for performing chromatographic separations are also provided.
    Type: Application
    Filed: February 3, 2005
    Publication date: October 6, 2005
    Applicant: Caliper Life Sciences, Inc.
    Inventors: Theo Nikiforov, Jill Baker, Sansan Lin, J. Parce, Jude Dunne, Javier Farinas, Esther Huang, Mingqing Li, Thi Trinh